Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03198221 · ClinicalTrials.gov registry record · Phase 4

Comparison of Clenpiq vs Golytely Bowel Preparation

A Phase 4 study, sponsored by The Cleveland Clinic.

Terminated
Registry status
Phase 4
Development phase
14
Enrollment target

NCT03198221 is a Phase 4 study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 14 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03198221, a Phase 4 study, was terminated before completion, sponsored by The Cleveland Clinic.

TERMINATED
Registry status
Phase 4
Development phase
14 participants
Enrollment target

Study Summary

This is a prospective randomized study which will be done at main campus Cleveland Clinic. The investigators will be comparing the colon cleansing by the Boston Bowel Preparation Scale in participants undergoing colonoscopy as an inpatient at our hospital. Participants will be randomized to the the standard of care (4 Liter polyethylene glycol based preparation) or a low volume bowel preparation (sodium picosulfate, a stimulant laxative, magnesium oxide and anhydrous citric acid (SP/MC)). Both agents will either be administered as full dose the evening before or as split-dose on the evening before and on the day of the procedure.

Interventions

  • DRUG Golytely
  • DRUG Clenpiq

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2018-07-11
Est. Completion 2019-03-26
Phase Phase 4

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT03198221

The ClinicalTrials.gov registry entry for NCT03198221 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Golytely is the first listed.

NCT03198221 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03198221 about?

NCT03198221 is a clinical study titled "Comparison of Clenpiq vs Golytely Bowel Preparation". This is a prospective randomized study which will be done at main campus Cleveland Clinic. The investigators will be comparing the colon cleansing by the Boston Bowel Preparation Scale in participants undergoing colonoscopy as an inpatient at our hospital. Participants will be randomized to the the ...

What is the current status of trial NCT03198221?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2018-07-11. Estimated completion is 2019-03-26.

What interventions are being tested in trial NCT03198221?

The interventions under investigation include: Golytely (DRUG), Clenpiq (DRUG).

Who is sponsoring clinical trial NCT03198221?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.